Triptolide Reduces MDA‐MB‐231 Cell Metastasis by Attenuating Epithelial‐Mesenchymal Transition through the ROCK/PTEN/Akt Axis
Chemistry & Biodiversity · 2023-12 · 20 (12)
DOI: 10.1002/cbdv.202300399 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 21.11.2023. Verfasst von Qinhang Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, P.R. China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Diterpenes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Natural Science Foundation of Nanjing University of Chinese Medicine, Nanjing University of Chinese Medicine.
Abstract (Originalsprache)
Triple‐negative breast cancer (TNBC) is a highly heterogeneous and invasive subtype of breast cancer. The prognosis of TNBC is poor because of its high distant metastasis rate. Triptolide is a type of diterpene trioxide natural compound with potential anti‐tumor activities. This study explored the metastatic inhibitory effect of triptolide on MDA‐MB‐231 cells and its underlying mechanism. Triptolide suppressed cell proliferation and induced cell apoptosis in a time‐ and dose‐dependent manner. Low doses of triptolide (0‐8 nM) reduced the migration and invasion capabilities of MDA‐MB‐231 cells. Triptolide decreased ROCK1, p‐Akt, N‐cadherin, vimentin and MMP‐9 expressions, but increased PTEN and E‐cadherin expressions on protein and mRNA levels. Furthermore, the down‐regulation of ROCK1 expression in MDA‐MB‐231 cells after being treated by triptolide could be rescued by ROCK1 specific inhibitor Y27632. Molecular docking showed that triptolide and Y27632 shared the same active center of ROCK1 protein. This article‘s findings taken together showed that ROCK1 is the primary target of triptolide, which can cause cell apoptosis and inhibit the epithelial‐mesenchymal transition of MDA‐MB‐231 cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, P.R. China.
- Department of Microbiology and Immunology, Wake Forest University, Winston-Salem, NC, 27101, USA.
ORCID-Profile: Qinhang Wu
Förderung
- National Natural Science Foundation of China
- National Natural Science Foundation of Nanjing University of Chinese Medicine
- Nanjing University of Chinese Medicine
Zitieren
APA
Wu, Q., Leng, X., Ma, X., Xu, Q., Ni, R., Pan, Y., Jin, Z., & Kalim, M. (2023). Triptolide Reduces MDA‐MB‐231 Cell Metastasis by Attenuating Epithelial‐Mesenchymal Transition through the ROCK/PTEN/Akt Axis. Chemistry & Biodiversity, 20(12). https://doi.org/10.1002/cbdv.202300399
Vancouver
Wu Q, Leng X, Ma X, Xu Q, Ni R, Pan Y, et al. Triptolide Reduces MDA‐MB‐231 Cell Metastasis by Attenuating Epithelial‐Mesenchymal Transition through the ROCK/PTEN/Akt Axis. Chemistry & Biodiversity. 2023;20(12). doi:10.1002/cbdv.202300399
BibTeX
@article{Wu2023,
author = {Wu, Qinhang and Leng, Xuejiao and Ma, Xuelin and Xu, Qixuan and Ni, Ruijun and Pan, Yang and Jin, Zhuolin and Kalim, Muhammad},
title = {Triptolide Reduces MDA‐MB‐231 Cell Metastasis by Attenuating Epithelial‐Mesenchymal Transition through the ROCK/PTEN/Akt Axis},
journal = {Chemistry & Biodiversity},
year = {2023},
volume = {20},
number = {12},
doi = {10.1002/cbdv.202300399}
}
EUVIMED